Results 31 to 40 of about 50,819 (268)

Effect of Fufang Huangqi Decoction on the Gut Microbiota in Patients With Class I or II Myasthenia Gravis

Frontiers in Neurology, 2022
ObjectiveTo investigate the effect of Fufang Huangqi Decoction on the gut microbiota in patients with class I or II myasthenia gravis (MG) and to explore the correlation between gut microbiota and MG (registration number, ChiCTR2100048367; registration ...
Yanghong Chen, Yi Lin, Caifeng Shan, Zhaoqing Li, Bo Xiao, Rencai He, Xueshi Huang, Zhanyou Wang, Jingsheng Zhang, Wenjun Qiao   +9 more
doaj   +1 more source

Classical complement pathway in experimental autoimmune myasthenia gravis pathogenesis

, 2021
Mice deficient for complement factors C3, C4, or C5 are resistant to experimental autoimmune myasthenia gravis (EAMG). Acetylcholine receptor (AChR) immune lymph node cells (LNC) of C3 deficient mice produce less interleukin 6 (IL-6), and EAMG-resistant ...
CHRISTADOSS, Premkumar, LI, Jing, SAINI, Shamsher S., YANG, Huan, Tuzun, Erdem   +4 more
core   +1 more source

Beyond Nature's Blueprint: Macrocyclic Peptides Containing Unnatural Amino Acids in Therapeutic Development

Angewandte Chemie, EarlyView.
Strategic incorporation of unnatural amino acids transforms macrocyclic peptides into drug‐like molecules capable of engaging challenging targets. These building blocks enhance stability, permeability, and bioavailability, accelerating the development of next‐generation peptide therapeutics.
Krishna K. Sharma, Komal Sharma, Anku Sharma, Kamya Rao, Rahul Jain, Brett VanVeller   +5 more
wiley   +2 more sources

Clinical features and HLA typing of immune checkpoint inhibitor-associated myasthenia gravis, myocarditis and myositis

Frontiers in Oncology
BackgroundImmune checkpoint inhibitors (ICI) have significantly improved the therapeutic outcomes for various malignant tumors, but they may also trigger severe immune-related adverse events (irAEs), such as myositis, myocarditis and myasthenia gravis ...
Xiaoting Lin, Xiaoting Lin, Xiaoting Lin, Peng Liu, Peng Liu, Peng Liu, Min Jin, Guoyan Qi, Guoyan Qi, Guoyan Qi   +9 more
doaj   +1 more source

HUBUNGAN ANTARA REGULASI EMOSI DENGAN KETABAHAN PADA PENDERITA MYASTHENIA GRAVIS

Jurnal Empati, 2020
Myasthenia gravis adalah penyakit autoimun yang terjadi ketika zat antibodi yang dibentuk oleh sistem kekebalan tubuh yang seharusnya berfungsi melindungi tubuh justru bekerja melawan jaringan yang ada di tubuhnya sendiri.
Nurmasari Puspita Ningtyas, Annastasia Ediati   +1 more
doaj   +1 more source

Myasthenia Gravis [PDF]

The Journal of Nervous and Mental Disease, 1903
n ...
openaire   +2 more sources

Myasthenia gravis [PDF]

, 1991
The thesis is 72 publications describing the author's hypothesis of an autoimmune basis for myasthenia gravis (MG) and its validation. At the time of the first 24 papers many considered that MG was a syndrome rather than a disease entity, due to a ...
Simpson, John Alexander
core   +3 more sources

Impact of SARS-CoV-2 infection on patients with myasthenia gravis: a retrospective study in a Chinese population

Frontiers in Neurology
Background and purposeMyasthenia gravis (MG) is characterized by fluctuating muscle weakness due to immune-mediated damage to acetylcholine receptors. Viral infections can exacerbate symptoms of muscle weakness, and the clinical status of patients with ...
Peng Liu, Peng Liu, Mengna Li, Liqing Li, Wenli Jia, Huimin Dong, Guoyan Qi, Guoyan Qi, Guoyan Qi   +8 more
doaj   +1 more source

Total drug treatment and comorbidity in myasthenia gravis: a population-based cohort study [PDF]

, 2014
Background and purpose: Comorbidity in myasthenia gravis (MG) is important for diagnosis, treatment and prognosis. Disease complexity was assessed by examining total drug treatment, immune therapy and comorbidity in a complete national MG cohort. Methods:
A. Engeland, J. F. Owe, Gilhus, Nils Erik, Andersen, Jintana Bunpan, Owe, Jone Furulund, J. B. Andersen, Engeland, Anders, N. E. Gilhus   +7 more
core   +1 more source

Case report: Efgartigimod combined with intravenous methylprednisolone in a case of co-occurrence of unexplained myasthenia gravis, inflammatory myopathy, and fulminant myocarditis

Frontiers in Immunology
The co-occurrence of myasthenia gravis (MG), inflammatory myopathy (IM), and fulminant myocarditis (FM) has rarely been reported. The few previous articles were mostly case reports or small sample data analysis, and the etiology was mostly attributed to ...
Hongxia Yang, Zulin Pan, Ying Yang, Yaxuan Wang, Biqi Cheng, Guoyan Qi   +5 more
doaj   +1 more source